Skip to content

Clinical trials

Recruiting Phase 1/2 Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 1/2 Status: Recruiting Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20201
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Iovance Biotherapeutics, Inc.1
MediLink Therapeutics (Suzhou) Co., Ltd.1
PEACHES BIOTECH1
Revolution Medicines, Inc.1
Thomas Advanced Medical LLC1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases6
Bronchial Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms3
Neoplasms3
Thoracic Neoplasms3
COVID-192
Carcinoma2
Colonic Neoplasms2
Gastrointestinal Neoplasms2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.